9-FLUORO-11-HYDROXY-16,17-((1-METHYLETHYLIDENE)BIS(OXY))-ANDROSTA-1,4-DIEN-3-ONE, (11.BETA.,16.ALPHA.,17.ALPHA.)-
UNII JC5K74SB75
Substance Identification & Data
This profile provides standardized clinical and technical data for 9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-androsta-1,4-dien-3-one, (11.beta.,16.alpha.,17.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JC5K74SB75.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 165739-48-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H29FO4 ZNDZRENZQNXJHA-CVJLFTMQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-androsta-1,4-dien-3-one, (11.beta.,16.alpha.,17.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.